The amplicons at 12q24, containing TBX3 and KDM2B, and at 16q22, containing E2F4, are recurrently targeted in HL, highlighting the potential activation of these genes in patients [73]. The gene discussed is E2F4; the disease is Hodgkins lymphoma.